| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 85.08 mm | 85.08 mm | 85.08 mm | 85.08 mm | 85.08 mm | 85.08 mm |
| Cash burn (monthly) | (no burn) | 1.20 mm | 19.31 mm | 24.60 mm | 8.46 mm | 17.40 mm |
| Cash used (since last report) | n/a | 4.84 mm | 77.68 mm | 98.97 mm | 34.03 mm | 69.99 mm |
| Cash remaining | n/a | 80.24 mm | 7.40 mm | -13.89 mm | 51.05 mm | 15.09 mm |
| Runway (months of cash) | n/a | 66.7 | 0.4 | -0.6 | 6.0 | 0.9 |
| 13F holders | Current |
|---|---|
| Total holders | 224 |
| Opened positions | 42 |
| Closed positions | 26 |
| Increased positions | 88 |
| Reduced positions | 59 |
| 13F shares | Current |
|---|---|
| Total value | 2.34 tn |
| Total shares | 85.76 mm |
| Total puts | 256.70 k |
| Total calls | 121.20 k |
| Total put/call ratio | 2.1 |
| Largest owners | Shares | Value |
|---|---|---|
| FMR | 11.14 mm | $356.96 bn |
| Vanguard | 6.71 mm | $215.09 bn |
| BlackRock | 5.94 mm | $190.38 bn |
| Deep Track Capital | 3.84 mm | $123.16 bn |
| T. Rowe Price | 3.52 mm | $112.67 mm |
| Boxer Capital | 3.42 mm | $109.63 bn |
| STT State Street | 3.09 mm | $99.02 bn |
| BC SW | 3.08 mm | $91.98 mm |
| Maverick Capital | 2.78 mm | $89.02 bn |
| PFE Pfizer | 2.34 mm | $145.05 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 10 Jan 25 | Saqib Islam | Common Stock | Grant | Acquire A | No | No | 0 | 74,834 | 0.00 | 1,050,502 |
| 10 Jan 25 | Saqib Islam | Stock Option Common Stock | Grant | Acquire A | No | No | 43 | 109,329 | 4.70 mm | 109,329 |
| 10 Jan 25 | Perier I Francis Jr | Common Stock | Grant | Acquire A | No | No | 0 | 11,779 | 0.00 | 60,889 |
| 10 Jan 25 | Perier I Francis Jr | Stock Option Common Stock | Grant | Acquire A | No | No | 43 | 34,419 | 1.48 mm | 34,419 |
| 10 Jan 25 | Badreddin Edris | Common Stock | Grant | Acquire A | No | No | 0 | 27,023 | 0.00 | 219,712 |
| 10 Jan 25 | Badreddin Edris | Stock Option Common Stock | Grant | Acquire A | No | No | 43 | 78,960 | 3.40 mm | 78,960 |
| 10 Jan 25 | Bhavesh Ashar | Common Stock | Grant | Acquire A | No | No | 0 | 17,323 | 0.00 | 63,069 |
| 10 Jan 25 | Bhavesh Ashar | Stock Option Common Stock | Grant | Acquire A | No | No | 43 | 50,615 | 2.18 mm | 50,615 |
| 10 Jan 25 | James Cassidy | Common Stock | Grant | Acquire A | No | No | 0 | 17,323 | 0.00 | 81,731 |
| 10 Jan 25 | James Cassidy | Stock Option Common Stock | Grant | Acquire A | No | No | 43 | 50,615 | 2.18 mm | 50,615 |
